Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 07 2023
Historique:
received: 21 03 2023
accepted: 23 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

The ability to use blood to predict the outcomes of Parkinson's disease, including disease progression and cognitive and motor complications, would be of significant clinical value. We undertook bulk RNA sequencing from the caudate and putamen of postmortem Parkinson's disease (n = 35) and control (n = 40) striatum, and compared molecular profiles with clinical features and bulk RNA sequencing data obtained from antemortem peripheral blood. Cognitive and motor complications of Parkinson's disease were associated with molecular changes in the caudate (stress response) and putamen (endothelial pathways) respectively. Later and earlier-onset Parkinson's disease were molecularly distinct, and disease duration was associated with changes in caudate (oligodendrocyte development) and putamen (cellular senescence), respectively. Transcriptome patterns in the postmortem Parkinson's disease brain were also evident in antemortem peripheral blood, and correlated with clinical features of the disease. Together, these findings identify molecular signatures in Parkinson's disease patients' brain and blood of potential pathophysiologic and prognostic importance.

Identifiants

pubmed: 37407548
doi: 10.1038/s41467-023-39652-6
pii: 10.1038/s41467-023-39652-6
pmc: PMC10322907
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3956

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS081706
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS117583
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107442
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG064596
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS111176
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS097404
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Brain. 2015 Jun;138(Pt 6):1658-66
pubmed: 25882651
Neurology. 2016 Apr 12;86(15):1400-1407
pubmed: 26865518
Genome Biol. 2010;11(2):R14
pubmed: 20132535
Sci Rep. 2017 Nov 22;7(1):16005
pubmed: 29167476
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nucleic Acids Res. 2015 Sep 3;43(15):e97
pubmed: 25925576
Aging Cell. 2012 Dec;11(6):996-1004
pubmed: 22882466
J Neurosci. 2003 Jul 16;23(15):6351-6
pubmed: 12867520
Arch Neurol. 1997 Feb;54(2):145-50
pubmed: 9041855
PLoS One. 2014 Aug 29;9(8):e102909
pubmed: 25170892
BMC Genomics. 2013 Aug 08;14:539
pubmed: 23927422
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Learn Mem. 2015 Jun 15;22(7):344-53
pubmed: 26077687
Neurology. 2005 Nov 8;65(9):1436-41
pubmed: 16275832
Lancet Neurol. 2006 Jun;5(6):525-35
pubmed: 16713924
Comput Methods Programs Biomed. 2019 Jul;175:223-231
pubmed: 31104710
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1098-1104
pubmed: 31079063
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Mov Disord. 2016 Mar;31(3):352-9
pubmed: 26853899
Brain. 2013 Aug;136(Pt 8):2419-31
pubmed: 23884810
Genes (Basel). 2022 Apr 21;13(5):
pubmed: 35627112
J Neurosci. 2013 Feb 6;33(6):2313-25
pubmed: 23392662
Brain. 2015 Sep;138(Pt 9):2659-71
pubmed: 26220939
J Biol Chem. 2016 Jan 29;291(5):2067-79
pubmed: 26663083
Cells. 2020 Aug 26;9(9):
pubmed: 32858884
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
NPJ Parkinsons Dis. 2020 Jan 3;6:3
pubmed: 31909184
Brain. 2020 Feb 1;143(2):661-673
pubmed: 31989163
Neurobiol Aging. 2012 Jun;33(6):1127.e11-20
pubmed: 22226489
Eur J Neurosci. 2018 Jan;47(1):1-16
pubmed: 29068110
Neurobiol Dis. 2006 Feb;21(2):305-13
pubmed: 16143538
Prog Neurobiol. 2008 Nov;86(3):141-55
pubmed: 18824075
Front Syst Neurosci. 2015 Oct 08;9:140
pubmed: 26500513
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
Brain. 2009 Nov;132(Pt 11):2947-57
pubmed: 19759203
Mov Disord. 2003 Nov;18(11):1250-6
pubmed: 14639664
J Neurosci. 2019 Nov 20;39(47):9306-9315
pubmed: 31597723
Brain. 2011 Aug;134(Pt 8):2339-57
pubmed: 21771855
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
J Comp Neurol. 2017 Feb 1;525(2):407
pubmed: 27917481
PLoS One. 2013;8(3):e58435
pubmed: 23472196
Oncotarget. 2016 Dec 6;7(49):81099-81109
pubmed: 27768595
Elife. 2021 Jun 15;10:
pubmed: 34128468
J Neurosci. 2008 Apr 16;28(16):4201-9
pubmed: 18417699
Sci Rep. 2020 Oct 21;10(1):17978
pubmed: 33087833
Arch Neurol. 2003 Mar;60(3):387-92
pubmed: 12633150
Nature. 2018 Oct;562(7728):578-582
pubmed: 30232451
Neurology. 1993 Jun;43(6):1150-8
pubmed: 8170560
Arch Neurol. 2000 Apr;57(4):470-5
pubmed: 10768619
Mech Ageing Dev. 2021 Dec;200:111589
pubmed: 34687726
Science. 2007 Aug 17;317(5840):951-3
pubmed: 17702943
Development. 1999 Mar;126(6):1317-26
pubmed: 10021349
Front Mol Neurosci. 2015 Dec 18;8:77
pubmed: 26733801
Lancet Neurol. 2006 Apr;5(4):355-63
pubmed: 16545752
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Neurology. 2009 Feb 17;72(7 Suppl):S32-8
pubmed: 19221312
Nat Neurosci. 2019 May;22(5):719-728
pubmed: 30936558
Neurology. 2007 Mar 27;68(13):1062-8
pubmed: 17389313
Cell Rep. 2018 Jan 23;22(4):930-940
pubmed: 29386135
Neurobiol Dis. 2022 Jun 1;167:105686
pubmed: 35272023
J Neurosci. 2006 Sep 13;26(37):9448-61
pubmed: 16971529
Prog Neurobiol. 2011 Dec;95(4):629-35
pubmed: 21930184
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Mov Disord. 2004 Sep;19(9):1020-8
pubmed: 15372591
Nat Aging. 2021 Aug;1(8):734-747
pubmed: 37117765
Brain. 2008 Jan;131(Pt 1):120-31
pubmed: 17956909
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477
pubmed: 30564614
J Neurosci. 2021 Feb 10;41(6):1191-1206
pubmed: 33328293
J Neurosci. 2014 Oct 22;34(43):14304-17
pubmed: 25339743
Nat Biotechnol. 2022 Jun;40(6):855-861
pubmed: 35132263
Curr Neurol Neurosci Rep. 2010 May;10(3):190-8
pubmed: 20425034
Nat Genet. 2020 May;52(5):482-493
pubmed: 32341526
Science. 1998 Feb 6;279(5352):863-7
pubmed: 9452386
Mov Disord. 2011 Feb 15;26(3):457-63
pubmed: 21229621
Sci Adv. 2020 Dec 9;6(50):
pubmed: 33298436

Auteurs

Krithi Irmady (K)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA. kirmady@rockefeller.edu.

Caryn R Hale (CR)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

Rizwana Qadri (R)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

John Fak (J)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

Sitsandziwe Simelane (S)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

Thomas Carroll (T)

Bioinformatics Resource Center, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.

Serge Przedborski (S)

Department of Neurology, Columbia University, 630 West 168th Street, New York, NY, 10032, USA.
Department of Pathology & Cell Biology, Columbia University, 630 West 168th Street, New York, NY, 10032, USA.
Department of Neuroscience, Columbia University, 630 West 168th Street, New York, NY, 10032, USA.

Robert B Darnell (RB)

Laboratory of Molecular Neuro-oncology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA. darnelr@rockefeller.edu.
Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA. darnelr@rockefeller.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH